Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
12/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $22 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $7 | $0 | $0 | – |
| Gross Profit | $15 | -$0 | -$0 | – |
| % Margin | 66.7% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | – |
| G&A Expenses | $0 | $2 | $0 | – |
| SG&A Expenses | $7 | $2 | $0 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $3 | $0 | $0 | – |
| Operating Expenses | $9 | $2 | $0 | – |
| Operating Income | -$2 | -$0 | -$0 | – |
| % Margin | -9.6% | – | – | – |
| Other Income/Exp. Net | -$7 | $2 | $0 | – |
| Pre-Tax Income | -$9 | -$0 | -$0 | – |
| Tax Expense | $0 | $0 | -$0 | – |
| Net Income | -$9 | -$0 | -$0 | – |
| % Margin | -40.2% | – | – | – |
| EPS | -756.01 | -0.17 | -0.041 | – |
| % Growth | -444,611.8% | -314.6% | – | – |
| EPS Diluted | -0.76 | -0.04 | -0.041 | – |
| Weighted Avg Shares Out | 12 | 2 | 9 | – |
| Weighted Avg Shares Out Dil | 12 | 10 | 9 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | -$7 | $0 | $0 | – |
| Depreciation & Amortization | $0 | -$4 | $0 | – |
| EBITDA | -$2 | -$4 | -$0 | – |
| % Margin | -9.6% | – | – | – |